Significance of protein kinase C in the neuropsychotoxicity induced by methamphetamine-like psychostimulants

Eun Joo Shin, Duy Khanh Dang, Young Gwang Hwang, Hai Quyen Tran, Naveen Sharma, Ji Hoon Jeong, Choon Gon Jang, Seung Yeol Nah, Toshitaka Nabeshima, Yukio Yoneda, Jean Lud Cadet, Hyoung Chun Kim

Research output: Contribution to journalReview article

Abstract

The abuse of methamphetamine (MA), an amphetamine (AMPH)-type stimulant, has been demonstrated to be associated with various neuropsychotoxicity, including memory impairment, psychiatric morbidity, and dopaminergic toxicity. Compelling evidence from preclinical studies has indicated that protein kinase C (PKC), a large family of serine/threonine protein kinases, plays an important role in MA-induced neuropsychotoxicity. PKC-mediated N-terminal phosphorylation of dopamine transporter has been identified as one of the prerequisites for MA-induced synaptic dopamine release. Consistently, it has been shown that PKC is involved in MA (or AMPH)-induced memory impairment and mania-like behaviors as well as MA drug dependence. Direct or indirect regulation of factors related to neuronal plasticity seemed to be critical for these actions of PKC. In addition, PKC-mediated mitochondrial dysfunction, oxidative stress or impaired antioxidant defense system has been suggested to play a role in psychiatric and cognitive disturbance induced by MA (or AMPH). In MA-induced dopaminergic toxicity, particularly PKCδ has been shown to trigger oxidative stress, mitochondrial dysfunction, pro-apoptotic changes, and neuroinflammation. Importantly, PKCδ may be a key mediator in the positive feedback loop composed of these detrimental events to potentiate MA-induced dopaminergic toxicity. This review outlines the role of PKC and its individual isozymes in MA-induced neuropsychotoxicity. Better understanding on the molecular mechanism of PKCs might provide a great insight for the development of potential therapeutic or preventive candidates for MA (or AMPH)-associated neuropsychotoxicity.

LanguageEnglish
Pages162-170
Number of pages9
JournalNeurochemistry International
Volume124
DOIs
Publication statusPublished - 01-03-2019

Fingerprint

Methamphetamine
Protein Kinase C
Amphetamine
Psychiatry
Oxidative Stress
Amphetamine-Related Disorders
Dopamine Plasma Membrane Transport Proteins
Neuronal Plasticity
Protein-Serine-Threonine Kinases
Bipolar Disorder
Isoenzymes
Substance-Related Disorders
Dopamine
Antioxidants
Phosphorylation
Morbidity

All Science Journal Classification (ASJC) codes

  • Cellular and Molecular Neuroscience
  • Cell Biology

Cite this

Shin, E. J., Dang, D. K., Hwang, Y. G., Tran, H. Q., Sharma, N., Jeong, J. H., ... Kim, H. C. (2019). Significance of protein kinase C in the neuropsychotoxicity induced by methamphetamine-like psychostimulants. Neurochemistry International, 124, 162-170. https://doi.org/10.1016/j.neuint.2019.01.014
Shin, Eun Joo ; Dang, Duy Khanh ; Hwang, Young Gwang ; Tran, Hai Quyen ; Sharma, Naveen ; Jeong, Ji Hoon ; Jang, Choon Gon ; Nah, Seung Yeol ; Nabeshima, Toshitaka ; Yoneda, Yukio ; Cadet, Jean Lud ; Kim, Hyoung Chun. / Significance of protein kinase C in the neuropsychotoxicity induced by methamphetamine-like psychostimulants. In: Neurochemistry International. 2019 ; Vol. 124. pp. 162-170.
@article{46de722d13e740669f413062d1ba2f78,
title = "Significance of protein kinase C in the neuropsychotoxicity induced by methamphetamine-like psychostimulants",
abstract = "The abuse of methamphetamine (MA), an amphetamine (AMPH)-type stimulant, has been demonstrated to be associated with various neuropsychotoxicity, including memory impairment, psychiatric morbidity, and dopaminergic toxicity. Compelling evidence from preclinical studies has indicated that protein kinase C (PKC), a large family of serine/threonine protein kinases, plays an important role in MA-induced neuropsychotoxicity. PKC-mediated N-terminal phosphorylation of dopamine transporter has been identified as one of the prerequisites for MA-induced synaptic dopamine release. Consistently, it has been shown that PKC is involved in MA (or AMPH)-induced memory impairment and mania-like behaviors as well as MA drug dependence. Direct or indirect regulation of factors related to neuronal plasticity seemed to be critical for these actions of PKC. In addition, PKC-mediated mitochondrial dysfunction, oxidative stress or impaired antioxidant defense system has been suggested to play a role in psychiatric and cognitive disturbance induced by MA (or AMPH). In MA-induced dopaminergic toxicity, particularly PKCδ has been shown to trigger oxidative stress, mitochondrial dysfunction, pro-apoptotic changes, and neuroinflammation. Importantly, PKCδ may be a key mediator in the positive feedback loop composed of these detrimental events to potentiate MA-induced dopaminergic toxicity. This review outlines the role of PKC and its individual isozymes in MA-induced neuropsychotoxicity. Better understanding on the molecular mechanism of PKCs might provide a great insight for the development of potential therapeutic or preventive candidates for MA (or AMPH)-associated neuropsychotoxicity.",
author = "Shin, {Eun Joo} and Dang, {Duy Khanh} and Hwang, {Young Gwang} and Tran, {Hai Quyen} and Naveen Sharma and Jeong, {Ji Hoon} and Jang, {Choon Gon} and Nah, {Seung Yeol} and Toshitaka Nabeshima and Yukio Yoneda and Cadet, {Jean Lud} and Kim, {Hyoung Chun}",
year = "2019",
month = "3",
day = "1",
doi = "10.1016/j.neuint.2019.01.014",
language = "English",
volume = "124",
pages = "162--170",
journal = "Neurochemistry International",
issn = "0197-0186",
publisher = "Elsevier Limited",

}

Shin, EJ, Dang, DK, Hwang, YG, Tran, HQ, Sharma, N, Jeong, JH, Jang, CG, Nah, SY, Nabeshima, T, Yoneda, Y, Cadet, JL & Kim, HC 2019, 'Significance of protein kinase C in the neuropsychotoxicity induced by methamphetamine-like psychostimulants', Neurochemistry International, vol. 124, pp. 162-170. https://doi.org/10.1016/j.neuint.2019.01.014

Significance of protein kinase C in the neuropsychotoxicity induced by methamphetamine-like psychostimulants. / Shin, Eun Joo; Dang, Duy Khanh; Hwang, Young Gwang; Tran, Hai Quyen; Sharma, Naveen; Jeong, Ji Hoon; Jang, Choon Gon; Nah, Seung Yeol; Nabeshima, Toshitaka; Yoneda, Yukio; Cadet, Jean Lud; Kim, Hyoung Chun.

In: Neurochemistry International, Vol. 124, 01.03.2019, p. 162-170.

Research output: Contribution to journalReview article

TY - JOUR

T1 - Significance of protein kinase C in the neuropsychotoxicity induced by methamphetamine-like psychostimulants

AU - Shin, Eun Joo

AU - Dang, Duy Khanh

AU - Hwang, Young Gwang

AU - Tran, Hai Quyen

AU - Sharma, Naveen

AU - Jeong, Ji Hoon

AU - Jang, Choon Gon

AU - Nah, Seung Yeol

AU - Nabeshima, Toshitaka

AU - Yoneda, Yukio

AU - Cadet, Jean Lud

AU - Kim, Hyoung Chun

PY - 2019/3/1

Y1 - 2019/3/1

N2 - The abuse of methamphetamine (MA), an amphetamine (AMPH)-type stimulant, has been demonstrated to be associated with various neuropsychotoxicity, including memory impairment, psychiatric morbidity, and dopaminergic toxicity. Compelling evidence from preclinical studies has indicated that protein kinase C (PKC), a large family of serine/threonine protein kinases, plays an important role in MA-induced neuropsychotoxicity. PKC-mediated N-terminal phosphorylation of dopamine transporter has been identified as one of the prerequisites for MA-induced synaptic dopamine release. Consistently, it has been shown that PKC is involved in MA (or AMPH)-induced memory impairment and mania-like behaviors as well as MA drug dependence. Direct or indirect regulation of factors related to neuronal plasticity seemed to be critical for these actions of PKC. In addition, PKC-mediated mitochondrial dysfunction, oxidative stress or impaired antioxidant defense system has been suggested to play a role in psychiatric and cognitive disturbance induced by MA (or AMPH). In MA-induced dopaminergic toxicity, particularly PKCδ has been shown to trigger oxidative stress, mitochondrial dysfunction, pro-apoptotic changes, and neuroinflammation. Importantly, PKCδ may be a key mediator in the positive feedback loop composed of these detrimental events to potentiate MA-induced dopaminergic toxicity. This review outlines the role of PKC and its individual isozymes in MA-induced neuropsychotoxicity. Better understanding on the molecular mechanism of PKCs might provide a great insight for the development of potential therapeutic or preventive candidates for MA (or AMPH)-associated neuropsychotoxicity.

AB - The abuse of methamphetamine (MA), an amphetamine (AMPH)-type stimulant, has been demonstrated to be associated with various neuropsychotoxicity, including memory impairment, psychiatric morbidity, and dopaminergic toxicity. Compelling evidence from preclinical studies has indicated that protein kinase C (PKC), a large family of serine/threonine protein kinases, plays an important role in MA-induced neuropsychotoxicity. PKC-mediated N-terminal phosphorylation of dopamine transporter has been identified as one of the prerequisites for MA-induced synaptic dopamine release. Consistently, it has been shown that PKC is involved in MA (or AMPH)-induced memory impairment and mania-like behaviors as well as MA drug dependence. Direct or indirect regulation of factors related to neuronal plasticity seemed to be critical for these actions of PKC. In addition, PKC-mediated mitochondrial dysfunction, oxidative stress or impaired antioxidant defense system has been suggested to play a role in psychiatric and cognitive disturbance induced by MA (or AMPH). In MA-induced dopaminergic toxicity, particularly PKCδ has been shown to trigger oxidative stress, mitochondrial dysfunction, pro-apoptotic changes, and neuroinflammation. Importantly, PKCδ may be a key mediator in the positive feedback loop composed of these detrimental events to potentiate MA-induced dopaminergic toxicity. This review outlines the role of PKC and its individual isozymes in MA-induced neuropsychotoxicity. Better understanding on the molecular mechanism of PKCs might provide a great insight for the development of potential therapeutic or preventive candidates for MA (or AMPH)-associated neuropsychotoxicity.

UR - http://www.scopus.com/inward/record.url?scp=85060106415&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85060106415&partnerID=8YFLogxK

U2 - 10.1016/j.neuint.2019.01.014

DO - 10.1016/j.neuint.2019.01.014

M3 - Review article

VL - 124

SP - 162

EP - 170

JO - Neurochemistry International

T2 - Neurochemistry International

JF - Neurochemistry International

SN - 0197-0186

ER -